Sanofi (SNY)
| Bid | 52 |
| Market Cap | 135.26B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 2.28 |
| PE Ratio (ttm) | 23.66 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 54.8 |
| Volume | 1,818,859 |
| Avg. Volume (20D) | 2,492,249 |
| Open | 54.10 |
| Previous Close | 54.50 |
| Day's Range | 53.83 - 54.34 |
| 52-Week Range | 45.22 - 58.97 |
| Beta | undefined |
About SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseas...
Analyst Forecast
According to 1 analyst ratings, the average rating for SNY stock is "Strong Buy." The 12-month stock price forecast is $60, which is an increase of 11.21% from the latest price.
2 weeks ago · proactiveinvestors.co.uk
L'Oréal to raise €3bn by selling block of shares back to SanofiL'Oréal will raise €3 billion by selling 29.6 million Sanofi shares back to Sanofi to cut its stake in the drugmaker. The French cosmetics giant, which also owns Garnier and Lancome, sold the shares ...
